By Traxx Mobility Systems
•
January 19, 2021
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease. The research collaboration between IMB’s Centre for Superbug Solutions and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. https://imb.uq.edu.au/article/2021/01/establishing-antibiotic-potential-cannabis